We then measured whether the method could detect an increase in CoA synthesis with PZ-2891, a pantazine compound that is effective in treating preclinical models of pantothenate kinase-associated neurodegeneration (PKAN) [34]. This evidence concerns the gene PANK1 and pantothenate kinase-associated neurodegeneration.